Drug intelligence / Profile preview

E-RH-06

Development stage: Preclinical
Lead developer: Clinical Research Labs

Overview

E-RH-06 is an investigational product evaluated in clinical trials for the treatment of symptoms related to upper respiratory tract conditions, specifically targeting nasal congestion and rhinorrhea. No definitive published data on its molecular composition, mechanism of action, or pharmacological class is currently available. Clinical studies have investigated E-RH-06 at different dose levels for its potential efficacy in reducing symptoms of seasonal nasal congestion or rhinorrhea, including patient populations with or without common colds[4][5][8].

Beyond the preview

Go deeper on E-RH-06.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on E-RH-06.

Explore the full profile